Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 32134161 | HLA-B (HLA-B) | pyrose | Thai | NA | NA | unclassified | |
| genotyping was performed by taqman rt-pcr (ephx1 337 t > c, ephx1 416a > g and cyp2c9*3), pyrosequencing (ugt1a1*28, ugt1a1*6) and polymerase chain reaction-sequence-specific oligonucleotide probe (hla-b). | |||||||
| 34089743 | HLA (HLA) | pyrose | NA | NA | NA | positive | |
| prenatal bpa exposure was associated with a higher methylation level of hla-drb6 in individuals as determined using pyrosequencing, which was consistent with the whole-genome methylation analysis results. | |||||||
| 17511033 | HLA-DR (HLA-DR) | dyspepsia | NA | NA | NA | unclassified | |
| aimto quantify the intraepithelial lymphocytes (iels) and to document the membrane expression of cd4, cd8, tcrgamma delta and adhesion and/or activation-associated molecules (cd103, cd28, cd44, cd69, hla-dr, cd95/fas) in the duodenal mucosa of patients with functional dyspepsia (fd) in order to provide arguments for an immunological process in fd. | |||||||
| 21951517 | HLA (HLA) | chorioamnionitis | NA | NA | NA | positive | |
| maternal hla panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis: evidence in support of the chronic nature of maternal anti-fetal rejection. | |||||||
| 21951517 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | chorioamnionitis | NA | NA | NA | unclassified | |
| there is a robust association between chronic chorioamnionitis and maternal seropositivity for anti-human leukocyte antigen (hla) panel-reactive antibodies (pra) at the time of delivery. | |||||||
| 21951517 | HLA (HLA) | chorioamnionitis | NA | NA | NA | unclassified | |
| this longitudinal study was performed to assess maternal hla pra status in early gestation and the temporal evolution of maternal hla pra in the context of chronic chorioamnionitis and, thereby, to determine whether hla pra during the course of pregnancy is useful for the detection of anti-fetal rejection. | |||||||
| 21951517 | HLA (HLA) | chorioamnionitis | NA | NA | NA | unclassified | |
| of studymaternal sera obtained before 16 weeks of gestation and at delivery were analyzed for hla pra in cases with (n = 100) and without (n = 150) chronic chorioamnionitis. | |||||||
| 21951517 | HLA-CLASS I (HLA CLASS II) | chorioamnionitis | NA | NA | NA | positive+negation | |
| igg (but not igm) hla class i and ii pra positivity at delivery was higher in cases with chronic chorioamnionitis than in those without chronic chorioamnionitis. | |||||||
| 21951517 | HLA-CLASS I (HLA CLASS II) | chorioamnionitis | NA | NA | NA | positive | |
| igg hla class i pra positivity before 16 weeks of gestation was higher in cases with chronic chorioamnionitis than in those without (30.3 versus 13.3% | |||||||
| 21951517 | HLA-CLASS I (HLA CLASS II) | chorioamnionitis | NA | NA | NA | unclassified | |
| positive conversion (negative hla pra before 16 weeks of gestation but positive at delivery) of igg hla class i and ii pra was significantly associated with chronic chorioamnionitis. | |||||||
Copyright 2024